Overview
Taylor Brooks is a Hematologist Oncology provider practicing medicine in Cleveland, Ohio. He has been practicing medicine for over 13 years.
Dr. Brooks is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Mantle Cell Lymphoma (MCL), Non-Hodgkin Lymphoma, B-Cell Lymphoma, and Follicular Lymphoma.
Dr. Brooks is board certified in American Board Of Internal Medicine, 2024. He is actively involved in clinical research, co-authoring 26 peer reviewed articles.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- PPO
- HMO
- EPO
- HMO
- PPO
- MEDICARE SNP
- MEDICARE MAPD
- OTHER MEDICARE
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- INDEMNITY
- PPO
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE PART D
- MEDICARE SNP
- HMO
- PPO
- HMO
- MANAGED MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
10201 Carnegie Avenue, Cleveland, OH 44106
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Cleveland Clinic Main Campus
Brian Hill is a Hematologist Oncology specialist and a Hematologist practicing medicine in Cleveland, Ohio. He has been practicing medicine for over 30 years. Dr. Hill is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration.
Cleveland Clinic Main Campus
Paolo Caimi is a Hematologist Oncology specialist and a Hematologist practicing medicine in Cleveland, Ohio. Dr. Caimi is highly rated in 37 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), B-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Caimi is board certified in American Board Of Internal Medicine, 2011.
Cleveland Clinic Main Campus
Aaron Gerds is a Hematologist Oncology specialist and a Hematologist practicing medicine in Cleveland, Ohio. He has been practicing medicine for over 24 years. Dr. Gerds is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Myelofibrosis, Myeloproliferative Neoplasms (MPN), Polycythemia Vera, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Gerds is board certified in American Board Of Internal Medicine, 2013.
Frequently Asked Questions about Dr. Taylor Brooks
How do I make an appointment with Dr. Taylor Brooks?
You can book an appointment with Dr. Taylor Brooks by calling their office at 866-223-8100. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Taylor Brooks a top-rated expert for Mantle Cell Lymphoma (MCL)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Taylor Brooks is classified as an Advanced expert for Mantle Cell Lymphoma (MCL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Taylor Brooks specialize in?
While Dr. Taylor Brooks is a Hematology Oncology, they have specific expertise in Mantle Cell Lymphoma (MCL), Non-Hodgkin Lymphoma, and B-Cell Lymphoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.
Does Dr. Taylor Brooks participate in research or clinical trials?
Yes. Dr. Taylor Brooks has published 26 articles and abstracts on conditions like Mantle Cell Lymphoma (MCL). You can view a list of Dr. Taylor Brooks's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Taylor Brooks accept my insurance?
Dr. Taylor Brooks accepts most major insurance plans, including Aetna and Ambetter. We recommend calling the office directly at 866-223-8100 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- B-Cell LymphomaDr. Brooks isAdvanced. Learn about B-Cell Lymphoma.
- Mantle Cell Lymphoma (MCL)Dr. Brooks isAdvanced. Learn about Mantle Cell Lymphoma (MCL).
- Non-Hodgkin LymphomaDr. Brooks isAdvanced. Learn about Non-Hodgkin Lymphoma.
- Experienced
- Anaplastic Large Cell LymphomaDr. Brooks isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- Classical Hodgkin LymphomaDr. Brooks isExperienced. Learn about Classical Hodgkin Lymphoma.
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Brooks isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Febrile NeutropeniaDr. Brooks isExperienced. Learn about Febrile Neutropenia.
- Follicular LymphomaDr. Brooks isExperienced. Learn about Follicular Lymphoma.
- Graft Versus Host Disease (GvHD)Dr. Brooks isExperienced. Learn about Graft Versus Host Disease (GvHD).